Company news
Organogenesis Holdings Inc. news in 2021
Organogenesis Holdings Inc.'s news releases, calls and decks from 2021, newest first.
Organogenesis Appoints Prathyusha Duraibabu to Board of Directors
November 21, 2021
Organogenesis Holdings Inc. Reports Third Quarter and First Nine Months 2021 Financial Results
November 8, 2021
Organogenesis Holdings Inc. to Participate in the Credit Suisse 30th Annual Healthcare Conference
November 7, 2021
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Fall 2021 Conference
October 26, 2021
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021
October 6, 2021
Organogenesis Holdings Inc. Reports Second Quarter and First Half 2021 Financial Results
August 8, 2021
Organogenesis Holdings Inc. Announces New $200 Million Credit Agreement with Silicon Valley Bank
August 8, 2021
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2021 Financial Results on August 9, 2021
July 1, 2021
Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results
May 9, 2021
Organogenesis Appoints Jon Giacomin to Board of Directors
May 9, 2021
CORRECTING and REPLACING – Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results
May 9, 2021
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring | WHS 2021 Virtual Meeting
May 5, 2021
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2021 Financial Results on May 10, 2021
April 11, 2021
Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 Guidance
March 15, 2021
Organogenesis Appoints David C. Francisco as Chief Financial Officer
February 15, 2021
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February and March
February 8, 2021
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 16, 2021
February 7, 2021
Organogenesis Enrolls First Patient in Pivotal Phase 3 Clinical Trial of RMAT-Designated ReNu® for Knee Osteoarthritis
January 13, 2021
Organogenesis Holdings Inc. Reports Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020
January 12, 2021
Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee
January 10, 2021
Organogenesis Holdings Inc. to Participate in the ICR Conference 2021
January 4, 2021
Calls in 2021
- Organogenesis Holdings (NASDAQ:ORGO) Q3 2021 Earnings Call
Nov 9, 2021
Transcript - Organogenesis Holdings (NASDAQ:ORGO) Q2 2021 Earnings Call
Aug 9, 2021
Transcript - Organogenesis Holdings (NASDAQ:ORGO) Q1 2021 Earnings Call
May 10, 2021
Transcript - Organogenesis Holdings (NASDAQ:ORGO) Q4 2020 Earnings Call
Mar 16, 2021
Transcript